Attention Spans To Remain Hazy For A Few More Months

“The FDA is now reporting that… the shortage is easing in some parts of the country. Pharmaceutical company Shire says there is ‘adequate’ availability of the brand-name version of Adderall, but generic versions remain in short supply. Drug manufacturer Mallinckrodt says it’s name-brand ADHD drug, Methylin, ‘will be increasingly available as supply recovery continues.’ This affects both the immediate- and extended-release versions of Methylin. But other ADHD drugs will remain in short supply for the first part of 2012.”